Written from the studies on PubMed, searched on 2026. nov. 11.. Every number below comes from a study listed under Sources.
The claim
Posts online say that omega-3 fatty acids (fish oil) helps with hypertrophic cardiomyopathy.
Where research stands
We found 3 published papers on omega-3 fatty acids (fish oil) and hypertrophic cardiomyopathy. They were published between 2005 and 2022. None of them is a study in people. 2 were studies in animals, and none was only in cells in the lab.
- 0In people
- 2In animals
- 0Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Omega-3 fatty acids (fish oil) has been studied for hypertrophic cardiomyopathy in animals, not yet in people.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis.2015 · Int Immunopharmacol · In animals
- Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.2005 · Cardiovasc Res · In animals
- The association between the clinical severity of heart failure and docosahexaenoic acid accumulation in hypertrophic cardiomyopathy.2022 · BMC Res Notes · Other paper
